Flow cytometric detection of the classical Hodgkin lymphoma: Clinical and research applications

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Roshal, Mikhail ^a,b   Wood, Brent L ^a   Fromm, Jonathan R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; PROTEIN BCL 2;

ANTIGEN EXPRESSION; CANCER CELL; CANCER DIAGNOSIS; CANCER RESEARCH; CELL ISOLATION; CLASSICAL HODGKIN LYMPHOMA; CLINICAL RESEARCH; DIAGNOSTIC TEST; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOCYTE; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; TUMOR MICROENVIRONMENT;

EID: 79251564717     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/387034     Document Type: Review

References (63)

1. Wood B. L., Borowitz M. J., McPherson R. A., The flow cytometric evaluation of hematopoietic neoplasia Henry's Clinical Diagnosis and Management by Laboratory Methods 2006 21st Philadelphia, Pa, USA Elsevier Saunders
2. Paiva B., Almeida J., Pérez-Andrs M., Mateo G., López A., Rasillo A., Vdriales M.-B., López-Berges M.-C., San Miguel J. F., Orfao A., Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders Cytometry Part B 2010 78 4 239 252
3. Kern W., Haferlach C., Haferlach T., Schnittger S., Monitoring of minimal residual disease in acute myeloid leukemia Cancer 2008 112 1 4 16
4. Campana D., Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic Leukemia Hematology/Oncology Clinics of North America 2009 23 5 1083 1098
5. Swerdlow S., Campo E., Harris N. L., World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 Lyon, France IARC Press
6. Carbone A., Gloghini A., The role of current and new discriminating markers in the immunodiagnosis of Hodgkin's disease and other phenotypically related lymphomas Pathologica 1996 88 3 169 174
7. Metkar S. S., Naresh K. N., Redkar A. A., Soman C. S., Advani S. H., Nadkarni J. J., Expression of Fas and Fas ligand in Hodgkin's disease Leukemia and Lymphoma 1999 33 5-6 521 530
8. Irsch J., Nitsch S., Hansmann M.-L., Rajewsky K., Tesch H., Diehl V., Jox A., Kppers R., Radbruch A., Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues Proceedings of the National Academy of Sciences of the United States of America 1998 95 17 10117 10122
9. Fromm J. R., Kussick S. J., Wood B. L., Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting American Journal of Clinical Pathology 2006 126 5 764 780
10. Fromm J. R., Thomas A., Wood B. L., Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity American Journal of Clinical Pathology 2009 131 3 322 332
11. Sanders M. E., Makgoba M. W., Sussman E. H., Luce G. E. G., Cossman J., Shaw S., Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428 Cancer Research 1988 48 1 37 40
12. Wood B. L., Ten-color immunophenotyping of hematopoietic cells Current Protocols in Cytometry 2005 6: unit6.21
13. Hernandez O., Oweity T., Ibrahim S., Is an increase in CD4/CD8 T-cell ratio in lymph node fine needle aspiration helpful for diagnosing Hodgkin lymphoma? A study of 85 lymph node FNAs with increased CD4/CD8 ratio CytoJournal 2005 2, article 14
14. Martin J. M. E., Warnke R. A., A quantitative comparison of T-cell subsets in Hodgkin's disease and reactive hyperplasia. Frozen section immunohistochemistry Cancer 1984 53 11 2450 2455
15. Hudnall S. D., Betancourt E., Barnhart E., Patel J., Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia Cytometry Part B 2008 74 1 1 8
16. Bosler D. S., Douglas-Nikitin V. K., Harris V. N., Smith M. D., Detection of T-regulatory cells has a potential role in the diagnosis of classical Hodgkin lymphoma Cytometry Part B 2008 74 4 227 235
17. Ishida T., Ishii T., Inagaki A., Yano H., Komatsu H., Iida S., Inagaki H., Ueda R., Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege Cancer Research 2006 66 11 5716 5722
18. Marshall N. A., Christie L. E., Munro L. R., Culligan D. J., Johnston P. W., Barker R. N., Vickers M. A., Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma Blood 2004 103 5 1755 1762
19. Barth S., Aleksza M., Keresztes K., Tth J., Sipka S., Szegedi G., Ills., Immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma Acta Haematologica 2006 116 3 181 185
20. Ma Y., Visser L., Blokzijl T., Harms G., Atayar., Poppema S., Van Den Berg A., The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile Laboratory Investigation 2008 88 5 482 490
21. Seegmiller A. C., Karandikar N. J., Kroft S. H., McKenna R. W., Xu Y., Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes Cytometry Part B 2009 76 3 169 174
22. Fromm J. R., Thomas A., Wood B. L., Increased expression of T cell antigens on T cells in classical Hodgkin lymphoma Cytometry B Clin Cytom 2010 78 6 387 8
23. Salipante S. J., Mealiffe M. E., Wechsler J., Krem M. M., Liu Y., Namkoong S., Bhagat G., Kirchhoff T., Offit K., Lynch H., Wiernik P. H., Roshal M., McMaster M. L., Tucker M., Fromm J. R., Goldin L. R., Horwitz M. S., Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells Proceedings of the National Academy of Sciences of the United States of America 2009 106 35 14920 14925
24. Rahemtullah A., Reichard K. K., Preffer F. I., Harris N. L., Hasserjian R. P., A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma American Journal of Clinical Pathology 2006 126 5 805 814
25. Hansmann M.-L., Fellbaum C., Hui P. K., Moubayed P., Progressive transformation of germinal centers with and without association to Hodgkin's disease American Journal of Clinical Pathology 1990 93 2 219 226
26. Rdiger T., Gascoyne R. D., Jaffe E. S., de Jong D., Delabie J., De Wolf-Peeters C., Poppema S., Xerri L., Gisselbrecht C., Wiedenmann S., Mller-Hermelink H. K., Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma Annals of Oncology 2002 13 supplement 1 44 51
27. Brenchley J. M., Karandikar N. J., Betts M. R., Ambrozak D. R., Hill B. J., Crotty L. E., Casazza J. P., Kuruppu J., Migueles S. A., Connors M., Roederer M., Douek D. C., Koup R. A., Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells Blood 2003 101 7 2711 2720
28. Hell K., Lorenzen J., Hansmann M. L., Fellbaum C., Busch R., Fischer R., Expression of the proliferating cell nuclear antigen in the different types of Hodgkin's disease American Journal of Clinical Pathology 1993 99 5 598 603
29. Kansal R., Singleton T. P., Ross C. W., Finn W. G., Padmore R. F., Schnitzer B., Follicular Hodgkin lymphoma: a histopathologic study American Journal of Clinical Pathology 2002 117 1 29 35
30. Boudov L., Torlakovic E., Delabie J., Reimer P., Pfistner B., Wiedenmann S., Diehl V., Mller-Hermelink H.-K., Rdiger T., Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma Blood 2003 102 10 3753 3758
31. Jones R. J., Gocke C. D., Kasamon Y. L., Miller C. B., Perkins B., Barber J. P., Vala M. S., Gerber J. M., Gellert L. L., Siedner M., Lemas M. V., Brennan S., Ambinder R. F., Matsui W., Circulating clonotypic B cells in classic Hodgkin lymphoma Blood 2009 113 23 5920 5926
32. Shafer J. A., Cruz C. R., Leen A. M., Ku S., Lu A., Rousseau A., Heslop H. E., Rooney C. M., Bollard C. M., Foster A. E., Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma Leukemia and Lymphoma 2010 51 5 870 880
33. Kastan M. B., Schlaffer E., Russo J. E., Colvin O. M., Civin C. I., Hilton J., Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells Blood 1990 75 10 1947 1950
34. Jones R. J., Barber J. P., Vala M. S., Collector M. I., Kaufmann S. H., Ludeman S. M., Colvin O. M., Hilton J., Assessment of aldehyde dehydrogenase in viable cells Blood 1995 85 10 2742 2746
35. Storms R. W., Trujillo A. P., Springer J. B., Shah L., Colvin O. M., Ludeman S. M., Smith C., Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity Proceedings of the National Academy of Sciences of the United States of America 1999 96 16 9118 9123
36. Hess D. A., Meyerrose T. E., Wirthlin L., Craft T. P., Herrbrich P. E., Creer M. H., Nolta J. A., Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity Blood 2004 104 6 1648 1655
37. Hess D. A., Wirthlin L., Craft T. P., Herrbrich P. E., Hohm S. A., Lahey R., Eades W. C., Creer M. H., Nolta J. A., Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells Blood 2006 107 5 2162 2169
38. Croker A. K., Goodale D., Chu J., Postenka C., Hedley B. D., Hess D. A., Allan A. L., High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability Journal of Cellular and Molecular Medicine 2009 13 8 B 2236 2252
39. Ma S., Kwok W. C., Lee T. K.-W., Kwan H. T., Wo J. Y.-H., Zheng B.-J., Guan X.-Y., Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations Molecular Cancer Research 2008 6 7 1146 1153
40. Povsic T. J., Zavodni K. L., Kelly F. L., Zhu S., Goldschmidt-Clermont P. J., Dong C., Peterson E. D., Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity Journal of the American College of Cardiology 2007 50 23 2243 2248
41. Cheung A. M. S., Wan T. S. K., Leung J. C. K., Chan L. Y. Y., Huang H., Kwong Y. L., Liang R., Leung A. Y. H., Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential Leukemia 2007 21 7 1423 1430
42. Corti S., Locatelli F., Papadimitriou D., Donadoni C., Salani S., Del Bo R., Strazzer S., Bresolin N., Comi G. P., Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity Stem Cells 2006 24 4 975 985
43. Goodell M. A., Rosenzweig M., Kim H., Marks D. F., Demaria M., Paradis G., Grupp S. A., Sieff C. A., Mulligan R. C., Johnson R. P., Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species Nature Medicine 1997 3 12 1337 1345
44. Hackett T.-L., Shaheen F., Johnson A., Wadsworth S., Pechkovsky D. V., Jacoby D. B., Kicic A., Stick S. M., Knight D. A., Characterization of side population cells from human airway epithelium Stem Cells 2008 26 10 2576 2585
45. Mathew G., Timm E. A. Jr. , Sotomayor P., Godoy A., Montecinos V. P., Smith G. J., Huss W. J., ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate Cell Cycle 2009 8 7 1053 1061
46. Matsui W., Wang Q., Barber J. P., Brennan S., Smith B. D., Borrello I., McNiece I., Lin L., Ambinder R. F., Peacock C., Watkins D. N., Huff C. A., Jones R. J., Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance Cancer Research 2008 68 1 190 197
47. Ono M., Maruyama T., Masuda H., Kajitani T., Nagashima T., Arase T., Ito M., Ohta K., Uchida H., Asada H., Yoshimura Y., Okano H., Matsuzaki Y., Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18700 18705
48. She J. J., Zhang P. G., Wang Z. M., Gan W. M., Che X. M., Identification of side population cells from bladder cancer cells by dyecycle violet staining Cancer Biology and Therapy 2008 7 10 1663 1668
49. Storms R. W., Goodell M. A., Fisher A., Mulligan R. C., Smith C., Hoechst dye efflux reveals a novel CD 7 + CD 34-lymphoid progenitor in human umbilical cord blood Blood 2000 96 6 2125 2133
50. Szotek P. P., Pieretti-Vanmarcke R., Masiakos P. T., Dinulescu D. M., Connolly D., Foster R., Dombkowski D., Preffer F., MacLaughlin D. T., Donahoe P. K., Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness Proceedings of the National Academy of Sciences of the United States of America 2006 103 30 11154 11159
51. Wulf G. G., Wang R.-Y., Kuehnle I., Weidner D., Marini F., Brenner M. K., Andreeff M., Goodell M. A., A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia Blood 2001 98 4 1166 1173
52. Sup S. J., Alemay C. A., Pohlman B., Elson P., Malhi S., Thakkar S., Steinle R., Hsi E. D., Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome Journal of Clinical Oncology 2005 23 16 3773 3779
53. Canioni D., Deau-Fischer B., Taupin P., Ribrag V., Delarue R., Bosq J., Rubio M.-T., Roux D., Vasiliu V., Varet B., Brousse N., Hermine O., Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases PLoS ONE 2009 4 7, article e6341
54. Portlock C. S., Donnelly G. B., Qin J., Straus D., Yahalom J., Zelenetz A., Noy A., O'Connor O., Horwitz S., Moskowitz C., Filippa D. A., Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease British Journal of Haematology 2004 125 6 701 708
55. Aldred V., Vassallo J., Froes M. Campos A. H. J., Augusto Soares F., CD20 expression by Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma is related to reduced overall survival in young adult patients Leukemia and Lymphoma 2008 49 11 2198 2202
56. Tzankov A., Zimpfer A., Pehrs A.-C., Lugli A., Went P., Maurer R., Pileri S., Dirnhofer S., Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases Modern Pathology 2003 16 11 1141 1147
57. lvaro T., Lejeune M., Salvad MA. T., Bosch R., Garca J. F., Jan J., Banham A. H., Roncador G., Montalbn C., Piris M. A., Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells Clinical Cancer Research 2005 11 4 1467 1473
58. lvaro-Naranjo T., Lejeune M., Salvad-Usach M. T., Bosch-Prncep R., Reverter-Branchat G., Jan-Martnez J., Pons-Ferr L. E., Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients Leukemia and Lymphoma 2005 46 11 1581 1591
59. Oudejans J. J., Jiwa N. M., Kummer J. A., Ossenkoppele G. J., Van Heerde P., Baars J. W., Kluin PH. M., Kluin-Nelemans J. C., Van Diest P. J., Middeldorp J. M., Meijer C. J. L. M., Activated cytotoxic T cells as prognostic marker in Hodgkin's disease Blood 1997 89 4 1376 1382
60. Snchez-Aguilera A., Montalbn C., de la Cueva P., Snchez-Verde L., Morente M. M., Garca-Coso M., Garca-Laraa J., Bellas C., Provencio M., Romagosa V., Fernndez De Sevilla A., Menrguez J., Sabn P., Mestre M. J., Mndez M., Fresno M. F., Nicols C., Piris M. A., Garca J. F., Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma Blood 2006 108 2 662 668
61. Montalbn C., Garca J. F., Abraira V., Gonzlez-Camacho L., Morente M. M., Bello J. L., Conde E., Cruz M. A., Garca-Sanz R., Garca-Laraa J., Grande C., Llanos M., Martnez R., Flores E., Mndez M., Ponders C., Rayn C., Snchez-Godoy P., Zamora J., Piris M. A., Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study Group Journal of Clinical Oncology 2004 22 9 1664 1673
62. Baur A. S., Meug-Moraw C., Michel G., Delacrtaz F., Prognostic value of follicular dendritic cells in nodular sclerosing Hodgkin's disease Histopathology 1998 32 6 512 520
63. Steidl C., Lee T., Shah S. P., Farinha P., Han G., Nayar T., Delaney A., Jones S. J., Iqbal J., Weisenburger D. D., Bast M. A., Rosenwald A., Muller-Hermelink H. -K., Rimsza L. M., Campo E., Delabie J., Braziel R. M., Cook J. R., Tubbs R. R., Jaffe E. S., Lenz G., Connors J. M., Staudt L. M., Chan W. C., Gascoyne R. D., Tumor-associated macrophages and survival in classic Hodgkin's lymphoma The New England Journal of Medicine 2010 362 10 875 885